Ursodeoxycholic acid and primary biliary cirrhosis.
作者信息
Lim A G, Northfield T C
出版信息
BMJ. 1994;309(6953):491-2. doi: 10.1136/bmj.309.6953.491.
Abstract
摘要
相似文献
1
Ursodeoxycholic acid and primary biliary cirrhosis.熊去氧胆酸与原发性胆汁性肝硬化
BMJ. 1994;309(6953):491-2. doi: 10.1136/bmj.309.6953.491.
2
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: first controlled data.熊去氧胆酸治疗原发性胆汁性肝硬化：首个对照数据。
Hepatology. 1990 Jul;12(1):172-3. doi: 10.1002/hep.1840120128.
3
Ursodeoxycholic acid for primary biliary cirrhosis.熊去氧胆酸用于原发性胆汁性肝硬化。
Cochrane Database Syst Rev. 2002(1):CD000551. doi: 10.1002/14651858.CD000551.
4
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.熊去氧胆酸用于治疗原发性胆汁性肝硬化。
N Engl J Med. 2007 Oct 11;357(15):1524-9. doi: 10.1056/NEJMct074694.
5
[Ursodeoxycholic acid in the treatment of primary biliary liver cirrhosis].
Gastroenterol Clin Biol. 1994;18(2 Pt 3):T5-8.
6
Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.熊去氧胆酸与原发性胆汁性肝硬化的长期生存
Am J Gastroenterol. 2004 Feb;99(2):269-70.
7
Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid.熊去氧胆酸治疗期间原发性胆汁性肝硬化的病情恶化。
Lancet. 1988 May 21;1(8595):1163. doi: 10.1016/s0140-6736(88)91974-5.
8
Use of ursodeoxycholic acid in primary biliary cirrhosis.熊去氧胆酸在原发性胆汁性肝硬化中的应用。
Ann Pharmacother. 1993 Dec;27(12):1472-4.
9
The ursodeoxycholic acid story in primary biliary cirrhosis.熊去氧胆酸在原发性胆汁性肝硬化中的应用历程
Gut. 1995 Sep;37(3):301-4. doi: 10.1136/gut.37.3.301.
10
[Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].原发性胆汁性肝硬化和原发性硬化性胆管炎的诊断与治疗
Z Gastroenterol. 2002 Dec;40 Suppl 2:29-30. doi: 10.1055/s-2002-35890.
引用本文的文献
1
Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.脱氧胆酸和熊去氧胆酸对培养巨噬细胞脂质过氧化的影响。
Gut. 1996 Sep;39(3):475-8. doi: 10.1136/gut.39.3.475.
本文引用的文献
1
Hepatoprotective properties of ursodeoxycholic acid.熊去氧胆酸的肝脏保护特性。
Gastroenterology. 1993 Jun;104(6):1865-70. doi: 10.1016/0016-5085(93)90672-y.
2
Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.原发性胆汁性肝硬化患者的血清胆汁酸：熊去氧胆酸治疗的效果
Hepatology. 1993 Apr;17(4):599-604. doi: 10.1002/hep.1840170412.
3
Molecular aspects of membrane stabilization by ursodeoxycholate [see comment].熊去氧胆酸对膜稳定作用的分子机制[见评论]
Gastroenterology. 1993 Jun;104(6):1736-44. doi: 10.1016/0016-5085(93)90653-t.
4
Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.原发性胆汁性肝硬化中，根据疾病严重程度对熊去氧胆酸（UDCA）的不同反应。
Dig Dis Sci. 1994 Jan;39(1):9-14. doi: 10.1007/BF02090053.
5
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.胆汁淤积性肝病中肝脏胆汁酸处理的动力学：熊去氧胆酸的作用
Gastroenterology. 1994 Jan;106(1):134-42. doi: 10.1016/s0016-5085(94)94899-2.
6
7
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.熊去氧胆酸治疗原发性胆汁性肝硬化
Gastroenterology. 1994 May;106(5):1284-90. doi: 10.1016/0016-5085(94)90021-3.
8
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.熊去氧胆酸用于原发性胆汁性肝硬化的长期治疗。熊去氧胆酸-原发性胆汁性肝硬化研究组。
N Engl J Med. 1994 May 12;330(19):1342-7. doi: 10.1056/NEJM199405123301903.
9
Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.熊去氧胆酸治疗慢性活动性肝炎患者胆结石并随访两年：一项初步研究
Dig Dis Sci. 1985 Jul;30(7):642-9. doi: 10.1007/BF01308413.
10
Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid.原发性胆汁性肝硬化中I类和II类主要组织相容性复合体分子的肝脏表达：熊去氧胆酸的作用。
Hepatology. 1990 Jan;11(1):12-5. doi: 10.1002/hep.1840110104.
Zotero 插件